We are monitoring the impact of COVID-19 & Recession alarm on MEA Prostate Cancer Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Prostate Cancer Market Research Report - Segmented By Diagnostic Techniques, Surgery, Radiation Therapy, Chemotherapy and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1541
Pages: 135

MEA Prostate Cancer Market Size (2022 to 2027)

The size of the prostate cancer market in the Middle East & Africa was valued at USD 5.03 billion in 2022 and expected to grow at a CAGR of 9.38%, to reach USD 7.88 billion by 2027 during the forecast period.

Prostate cancer is an abnormal and uncontrolled growth of cells in the prostate gland of a male individual. The majority of prostate cancers are developed sporadically in which genetic changes occur after birth. Although the cause of prostate cancer is largely unknown, some of the prime factors associated with the disease include obesity, overweight and past history of certain cancers. In addition, a person with cardiovascular disease is more prone to advanced metastatic cancer.

Promising drug pipeline, developing treatment patterns, rising untapped non-metastatic prostate cancer space, and increased patient awareness are the factors that are expected to enhance the market growth. In addition, improved government funding towards cancer and growing awareness about prostate cancer would be one of the prime reasons for the unparalleled market growth.

Stringent regulations are restraining the growth of the prostate cancer market in the MEA region.

This research report on the Middle East and Africa prostate cancer market has been segmented and sub-segmented into the following categories.

By Diagnostic Techniques: 

  • Digital Rectal Exam (DRE)
  • Prostate-Specific Antigen Test (PSA)

By Surgery: 

  • Radical Prostatectomy
  • Orchidectomy
  • Trans Urethral Resection (TUR)

By Radiation Therapy: 

  • External Beam Radiation Therapy
  • Brachytherapy

By Chemotherapy: 

  • Docetaxel
  • Etoposide
  • Vinblastine
  • Carboplatin
  • Vinorelbine

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the South African prostate cancer market is predicted to account for the largest share among others in the MEA region during the forecast period, owing to a growing focus on prostate cancer diagnostics products and increased awareness of the disease. In addition, prostate cancer growth is closely linked to age, and with the growing geriatric population, there is a significant increase in prostate cancer incidence. This is projected to drive the prostate cancer diagnostics market by increasing the demand for diagnostics products to detect the condition.

During the forecast period, technological developments in diagnostic tests are expected to boost MEA market expansion further. According to the National Cancer Institute, researchers are now studying the use of artificial intelligence to identify prostate cancer. During a Magnetic Resonance Imaging scan, AI technologies identify problem spots that require biopsies to validate the diagnosis. It is the second leading cause of cancer morbidity and mortality among Ethiopian men. Despite a few studies on the disease burden, evidence on prostate cancer patients' survival and prognostic variables in Ethiopia is limited. As a result, the survival and predictive variables of individuals with prostate cancer were explored in this research. With the increase in new market players aiming to enter into the business through distribution agreements and investing in prostate cancer diagnosis, the sector is expected to expand, creating an opportunity for the prostate cancer diagnostics market.

KEY MARKET PLAYERS:

Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech are some of the notable companies in the MEA prostate cancer market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Techniques                           

                                5.1.1 Introduction           

                                5.1.2 Digital Rectal Exam (DRE)  

                                5.1.3 Prostate Specific Antigen Test (PSA)            

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Surgery                        

                                5.2.1 Introduction           

                                5.2.2 Radical Prostatectomy       

                                5.2.3 Orchidectomy        

                                5.2.4 Trans Urethral Resection (TUR)      

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Radiation Therapy                   

                                5.3.1 Introduction           

                                5.3.2 External Beam Radiation Therapy  

                                                5.3.2.1 3D Conformal Radiation Therapy

                                                5.3.2.2 Intensity Modulated Radiation Therapy

                                                5.3.2.3 Stereotactic Body Radiation Therapy

                                                5.3.2.4 Proton Beam Radiation Therapy

                                5.3.3 Brachytherapy      

                                                5.3.3.1 Permanent Brachytherapy

                                                5.3.3.2 Temporary Brachytherapy

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5 Market Attractiveness Analysis, By Application        

                                5.3.6 Market Share Analysis, By Application         

                5.4 Chemotherapy                         

                                5.4.1 Introduction           

                                5.4.2 Docetaxel

                                5.4.3 Etoposide

                                5.4.4 Vinblastine             

                                5.4.5 Carboplatin             

                                5.4.6 Vinorelbine            

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications          

                                5.4.8 Market Attractiveness Analysis, By Disease Indications        

                                5.4.9 Market Share Analysis, By Disease Indications         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Techniques

                                                6.1.3.3 By Surgery

                                                6.1.3.4 By Radiation Therapy

                                                6.1.3.5 By Chemotherapy

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Techniques

                                                6.1.4.3 By Surgery

                                                6.1.4.4 By Radiation Therapy

                                                6.1.4.5 By Chemotherapy

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Techniques

                                                6.1.5.3 By Surgery

                                                6.1.5.4 By Radiation Therapy

                                                6.1.5.5 By Chemotherapy

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Sanofi S.A                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline                      

                8.3 AstraZeneca               

                8.4 AbbVie                         

                8.5 Varian Medical Systems                        

                8.6 Elekta                           

                8.7 Theragenics               

                8.8 Pfizer                            

                8.9 Novartis                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Middle East & Africa Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  2. Middle East & Africa Digital Rectal Exam (DRE) Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Prostate Specific Antigen Test (PSA) Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Radical Prostatectomy Market, By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Orchidectomy Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Trans Urethral Resection (TUR) Market, By Region, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  9. Middle East & Africa External Beam Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Brachytherapy Market, By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  12. Middle East & Africa Docetaxel Market, By Region, From 2022 - 2027 (USD Million)
  13. Middle East & Africa Etoposide Market, By Region, From 2022 - 2027 (USD Million)
  14. Middle East & Africa Vinblastine Market, By Region, From 2022 - 2027 (USD Million)
  15. Middle East & Africa Carboplatin Market, By Region, From 2022 - 2027 (USD Million)
  16. Middle East & Africa Vinorelbine Market, By Region, From 2022 - 2027 (USD Million)
  17. Middle East Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  18. Middle East Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  19. Middle East Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  20. Middle East Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  21. Africa Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  22. Africa Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  23. Africa Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  24. Africa Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  25. Middle East & Africa Prostate Cancer Market, By External Beam Radiation Therapy, From 2022 - 2027 (USD Million)
  26. Middle East & Africa 3D Conformal Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  27. Middle East & Africa Intensity Modulated Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  28. Middle East & Africa Stereotactic Body Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  29. Middle East & Africa Proton Beam Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  30. Middle East Prostate Cancer Market, By External Beam Radiation Therapy, From 2022 - 2027 (USD Million)
  31. Africa Prostate Cancer Market, By External Beam Radiation Therapy, From 2022 - 2027 (USD Million)
  32. Middle East & Africa Prostate Cancer Market, By Brachytherapy, From 2022 - 2027 (USD Million)
  33. Middle East & Africa Permanent Brachytherapy Market, By Region, From 2022 - 2027 (USD Million)
  34. Middle East & Africa Temporary Brachytherapy Market, By Region, From 2022 - 2027 (USD Million)
  35. Middle East Prostate Cancer Market, By Brachytherapy, From 2022 - 2027 (USD Million)
  36. Africa Prostate Cancer Market, By Brachytherapy, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample